DiaSorin Group to Develop Automated Zika Virus Diagnostic Test Under HHS Contract
Italy-based diagnostics company DiaSorin Group has received a $2.6 million contract from the U.S. Department of Health and Human Services to further develop a laboratory test designed to help clinicians identify Zika virus infection in blood samples. DiaSorin is developing a Zika diagnostic serological test based on the company’s LIAISON XL automated chemiluminescence analyzer that works to simultaneously run tests on up […] More